Treatment of addictive behaviors in liver transplant patients

Liver Transplantation

Volumn 13, Issue 11 SUPPL. 2, 2007, Pages

  Weinrieb, Robert M ^a   Lucey, Michael R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; METHADONE; MODAFINIL; NALOXONE; NALTREXONE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; OPIATE; PLACEBO; VARENICLINE;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ANALGESIA; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; DRUG USE; HUMAN; INSOMNIA; LIVER TOXICITY; LIVER TRANSPLANTATION; METHADONE TREATMENT; NARCOLEPSY; NICOTINE REPLACEMENT THERAPY; OPIATE ADDICTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOTHERAPY; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ALCOHOLISM; ANALGESICS, OPIOID; BEHAVIOR, ADDICTIVE; CANNABIS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; OPIOID-RELATED DISORDERS; PAIN; TOBACCO USE DISORDER;

EID: 36448982503     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21340     Document Type: Article

References (24)

1. Pfitzmann R, Schwenzer J, Rayes N, Sechofer D, Neuhaus R, Nussler N. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007;13:197-205.
2. Mells G, Neuberger J. Reducing the risks of cardiovascular disease in liver allograft recipients. Transplantation 2007; 83:1141-1150.
3. Wagner CC, Haller DL, Olbrisch ME. Relapse prevention treatment for liver transplant patients. J Clin Psychol Med Settings 1996;3:387-398.
4. DiMartini A, Day N, Dew MA, Lane T, Fitzgerald MG, Magill J, et al. Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics 2001:42: 55-62.
5. Weinrieb RM, Van Horn DH, McLellan AT, Volpicelli JR, Calarco JS, Lucey MR. Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates. J Addictive Dis 2001:20:105-119.
6. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992;49:876-880.
7. Weinrieb RM, Van Hom DH, Mclellan AT, Alterman AI, Calacco JS, O'Brien CP, et al. Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed. Psychosomatics 2001;42:111-115.
8. Georgiou G, Webb K, Griggs K, Copello A, Neuberger J, Day E. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl 2003;9:772-775.
9. Weinrieb R, Van Horn D, De Piano M, Lynch K, Lucey M. Alcoholism treatment before liver transplant: a randomized, controlled study of motivational enhancement therapy/case management (MET/CM) vs treatment as usual (TAU). In preparation.
10. Ball J, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York, NY: Springer-Verlag; 1991.
11. Kanchana TP, Kaul V, Manzarbeitia C, Reich DJ, Hails KC, Munoz SJ, et al. Liver transplantation for patients on methadone maintenance. Liver Transpl 2002;8:778-782.
12. Liu LU, Schiano TD, Lau N, O'Rourke M, Min AD, Sigal SH, et al. Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transpl 2003;3:1273-1277.
13. Weinrieb R, Barnett R, Lynch K, De Piano M, Atanda A, Olthoff K. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Liver Transpl 2004;10:97-106.
14. Trescot AM, Boswell MV, Atluri SL, Hansen HC, Deer TR, Abdi S, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician 2006;9:1-39.
15. DiMartini A, Javed L, Russell S, Dew MA, Fitzgerald MG, Jain A, et al. Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl 2005;11:679-683.
16. Pungpapong S, Manzarbeitia C, Ortiz J, Reich DJ, Araya V, Rothstein KD, et al. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl 2002;8:582-587.
17. Johnston S, Morris J, Cramb R, Gunson B, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002;73:901-906.
18. Muñoz S. Tobacco use by liver transplant recipients: grappling with a smoking gun. Liver Transpl 2005;11:606-609.
19. Leeman RF, Huffman CJ, O'Malley SS. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varencicline trials: a review. Alcohol Alcohol 2007;42:196-206.
20. Hall S, Humfleet G, Reus V, Munoz R, Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry 2004;161:2100-2107.
21. Block R, Farnham S, Braverman K, Noyes RJ, Ghoneim M. Residual effects of abused drugs on behavior. In: Spencer JW et al, eds. Long Term Marijuana Use and Subsequent Effects on Learning and Cognitive Functions Related to School Achievement: Preliminary Study. National Institutes on Drug Abuse Treatment Research Monograph Series 1990. DHHS Publication. Rockville, MD: National Institutes on Drug Abuse; 1990:96-111.
22. Hamadeh R, Ardehali A, Locksley RM, York MK. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient. Chest 1988;94: 432-433.
23. Marks WH, Florence L, Lieberman J, Chapman P, Howard D, Roberts P, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 1996;27: 1771-1774.
24. Dackis C, Kampman K, Lynch K, Pettinati H, O'Brien C. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005;30:205-211.